Biliary strictures in living donor liver transplantation: Incidence, management, and technical evolution

Yuji Soejima, Akinobu Taketomi, Tomoharu Yoshizumi, Hideaki Uchiyama, Noboru Harada, Hideki Ijichi, Yusuke Yonemura, Tetsuo Ikeda, Mitsuo Shimada, Yoshihiko Maehara – 23 May 2006 – Biliary complications, biliary strictures (BS) in particular, continue to be a significant cause of morbidity after LDLT despite technical refinement. In this study, we assessed the incidence of BS and their management in living donor liver transplantation (LDLT) with special reference to the type of biliary reconstruction.

Successful ABO‐incompatible pediatric liver transplantation utilizing standard immunosuppression with selective postoperative plasmapheresis

Thomas Heffron, David Welch, Todd Pillen, Massimo Asolati, Gregory Smallwood, Phil Hagedorn, Chang Nam, Alexander Duncan, Mark Guy, Enrique Martinez, James Spivey, Patricia Douglas, Carlos Fasola, Jill De Paolo, John Rodriguez, Rene Romero – 23 May 2006 – Transplanting blood group A, B, or O (ABO)‐incompatible (ABO‐I) liver grafts has resulted in lower patient and graft survival with an increased incidence of vascular and biliary complications and rejection.

Five‐year follow‐up of a hepatitis B virus‐positive recipient of hepatitis B surface antigen‐positive living donor liver graft

Shin Hwang, Sung‐Gyu Lee, Kwang‐Min Park, Ki‐Hun Kim, Chul‐Soo Ahn, Heung‐Bum Oh, Deok‐Bog Moon, Tae‐Yong Ha, Young‐Suk Lim, Dong‐Hwan Jung – 23 May 2006 – The shortage of cadaveric donor organs has led to the use of living donors and marginal cadaveric donors. To date, there have been only 2 reports on the use of hepatitis B surface antigen (HBsAg)‐positive liver grafts. Here we describe the 5‐yr posttransplantation sequence of a hepatitis B virus (HBV)‐positive recipient who received an HBsAg‐positive living donor liver graft.

Subscribe to